Amos Bar-Shalev - 18 Nov 2025 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
Issuer symbol
PLX
Transactions as of
18 Nov 2025
Transactions value $
-$314
Form type
4
Filing time
19 Nov 2025, 16:34:55 UTC
Previous filing
04 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bar-Shalev Amos Director C/O PROTALIX BIOTHERAPEUTICS, INC., 2 SNUNIT STREET SCIENCE PARK, POB 455, CARMIEL, ISRAEL /s/ Joseph R. Magnas, Attorney-in-Fact 19 Nov 2025 0001385113

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Sale -$314 -168 -100% $1.87 0 18 Nov 2025 Direct
holding PLX Common Stock 7.5K 18 Nov 2025 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended must be registered in the name of a trustee.